82
|
305
|
7urbB |
Sars-cov2 main protease in complex with cdd-1733 |
85
|
306
|
7ur9A |
Sars-cov2 main protease in complex with inhibitor cdd-1845 |
77
|
229
|
8i65A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with isoorotic acid (2,4-dihydroxypyrimidine-5-carboxylic acid), form i |
77
|
229
|
8i6bA |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with 5-hydroxy-2,4(1h,3h)-pyrimidinedione, form i |
80
|
301
|
8gfnA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with bbh1 |
78
|
229
|
8i62A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with barbituric acid, form i |
71
|
222
|
8i6dA |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with 5-hydroxy-2,4(1h,3h)-pyrimidinedione, form vi |
71
|
227
|
8i6cA |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with 6-formyl-uracil, form iii |
76
|
228
|
8i69A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with 5-fluoroorotic acid and citric acid, form i |
86
|
302
|
8gfrA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nbh2 |
71
|
224
|
8i6aA |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with orotic acid, form iii |
83
|
302
|
8gfoA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with gc373 |
79
|
228
|
8i67A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with 2,4-thiazolidinedione, form i |
71
|
223
|
8i68A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with uric acid, form iii |
73
|
228
|
8i66A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with isoorotic acid (2,4-dihydroxypyrimidine-5-carboxylic acid) and citric acid, form i |
69
|
224
|
8i64A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with barbituric acid, form ii |
82
|
302
|
8gfuA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nirmatrelvir (nmv) |
72
|
223
|
8i63A |
Crystal structure of mycobacterium tuberculosis uracil-dna glycosylase in complex with barbituric acid, form iii |
114
|
287
|
7y8mA |
Structure of scired-r2-v3 from streptomyces clavuligerus in complex with 5-(3-fluorophenyl)-3,4-dihydro-2h-pyrrole |
224
|
715
|
7y4gA |
Sit-bound btdpp4 |
68
|
219
|
7yhaA |
Crystal structure of imp-1 mbl in complex with (3-(4-(p-tolyl)-1h-1,2,3-triazol-1-yl)benzyl)phosphonic acid |
72
|
231
|
7yhbA |
Crystal structure of vim-2 mbl in complex with (2-(4-phenyl-1h-1,2,3-triazol-1-yl)benzyl)phosphonic acid |
71
|
231
|
7yhdA |
Crystal structure of vim-2 mbl in complex with 3-(4-(4-(2-aminoethoxy)phenyl)-1h-1,2,3-triazol-1-yl)phthalic acid |
68
|
219
|
7yh9A |
Crystal structure of imp-1 mbl in complex with 3-(4-benzyl-1h-1,2,3-triazol-1-yl)phthalic acid |
73
|
231
|
7yhcA |
Crystal structure of vim-2 mbl in complex with 3-(4-(3-aminophenyl)-1h-1,2,3-triazol-1-yl)phthalic acid |
18
|
99
|
8fuiA |
Hiv-1 wild type protease with grl-02519a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group |
18
|
99
|
8fujA |
Hiv-1 wild type protease with grl-03419a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group and 3,5-difluorophenylmethyl as the p1 group |
88
|
306
|
8dmdA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound zz4461624291 |
60
|
319
|
8gmnA |
Crystal structure of human c1s in complex with inhibitor |
92
|
300
|
7t1dA |
Human sirt2 in complex with small molecule 359 |
28
|
99
|
8g45A |
Structure of hdac6 zinc-finger ubiquitin binding domain in complex with sgc-ubd253 chemical probe |
28
|
99
|
8g44A |
Structure of hdac6 zinc-finger ubiquitin binding domain in complex with 3-(3-(2-(benzylamino)-2-oxoethyl)-4-oxo-3,4-dihydroquinazolin-2-yl)propanoic acid |
28
|
99
|
8g43A |
Structure of hdac6 zinc-finger ubiquitin binding domain in complex with 3-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-3,4-dihydroquinazolin-2-yl)propanoic acid |
24
|
103
|
8g26C |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 8.5 |
51
|
223
|
8g26A |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 8.5 |
40
|
218
|
8g25B |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 7.5 |
42
|
218
|
8g24B |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 5.5 |
24
|
103
|
8g24C |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 5.5 |
42
|
218
|
8g26B |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 8.5 |
55
|
223
|
8g25A |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 7.5 |
53
|
223
|
8g24A |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 5.5 |
25
|
103
|
8g25C |
Crystal structure of cathepsin-g and neutrophil elastase inhibited by s. aureus eaph2 at ph 7.5 |
139
|
356
|
8eqiA |
Crystal structure of danio rerio histone deacetylase 6 catalytic domain 2 complexed with cyclopeptide des4.2.0 |
81
|
244
|
8culA |
Xray ray crystal structure of oxa-24/40 in complex with cr167 |
89
|
311
|
8euaA |
Structure of sars-cov2 plpro bound to a covalent inhibitor |
121
|
358
|
8cuqA |
X-ray crystal structure of adc-33 in complex with sulfonamidoboronic acid 6e |
82
|
244
|
8cumA |
X-ray crystal structure of oxa-24/40 in complex with sulfonamidoboronic acid 6d |
120
|
358
|
8cupA |
X-ray crystal structure of adc-33 in complex with sulfonamidoboronic acid 6d |
84
|
244
|
8cuoA |
X-ray crystal structure of oxa-24/40 in complex with sulfonamidoboronic acid 6e |
18
|
99
|
8esxA |
Hiv protease in complex with benzoxaborolone analog of darunavir |